These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26082336)

  • 41. Gastric feed intolerance is not increased in critically ill patients with type II diabetes mellitus.
    Lam SW; Nguyen NQ; Ching K; Chapman M; Fraser RJ; Holloway RH
    Intensive Care Med; 2007 Oct; 33(10):1740-5. PubMed ID: 17554523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between blood glucose control and intolerance to enteral feeding during critical illness.
    Nguyen N; Ching K; Fraser R; Chapman M; Holloway R
    Intensive Care Med; 2007 Dec; 33(12):2085-92. PubMed ID: 17909745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of aspiration and gastrointestinal complications in critically ill patients using continuous versus bolus infusion of enteral nutrition: a pseudo-randomised controlled trial.
    Kadamani I; Itani M; Zahran E; Taha N
    Aust Crit Care; 2014 Nov; 27(4):188-93. PubMed ID: 24508516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feed intolerance in critical illness is associated with increased basal and nutrient-stimulated plasma cholecystokinin concentrations.
    Nguyen NQ; Fraser RJ; Chapman MJ; Bryant LK; Holloway RH; Vozzo R; Wishart J; Feinle-Bisset C; Horowitz M
    Crit Care Med; 2007 Jan; 35(1):82-8. PubMed ID: 17095943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of delaying enteral feeding on gastric emptying, plasma cholecystokinin, and peptide YY concentrations in critically ill patients.
    Nguyen NQ; Fraser RJ; Bryant LK; Burgstad C; Chapman MJ; Bellon M; Wishart J; Holloway RH; Horowitz M
    Crit Care Med; 2008 May; 36(5):1469-74. PubMed ID: 18434906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interruptions in enteral nutrition delivery in critically ill patients and recommendations for clinical practice.
    Stewart ML
    Crit Care Nurse; 2014 Aug; 34(4):14-21; quiz 22. PubMed ID: 25086090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Study of erythromycin and metoclopramide in treatment of feeding intolerance of critically ill patients in intensive care unit].
    Lu NF; Zheng RQ; Lin H; Yang DG; Chen QH; Shao J; Yu JQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Jan; 22(1):36-9. PubMed ID: 20092709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastric tonometry: a new monitoring modality in the intensive care unit.
    Gutierrez G; Brown SD
    J Intensive Care Med; 1995; 10(1):34-44. PubMed ID: 10155169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intragastric nitric oxide is abolished in intubated patients and restored by nitrite.
    Björne H; Govoni M; Törnberg DC; Lundberg JO; Weitzberg E
    Crit Care Med; 2005 Aug; 33(8):1722-7. PubMed ID: 16096448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased gastric PCO2 during exercise is indicative of gastric ischaemia: a tonometric study.
    Kolkman JJ; Groeneveld AB; van der Berg FG; Rauwerda JA; Meuwissen SG
    Gut; 1999 Feb; 44(2):163-7. PubMed ID: 9895373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients?
    Walsh TS; McArdle F; McLellan SA; Maciver C; Maginnis M; Prescott RJ; McClelland DB
    Crit Care Med; 2004 Feb; 32(2):364-71. PubMed ID: 14758149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms underlying feed intolerance in the critically ill: implications for treatment.
    Deane A; Chapman MJ; Fraser RJ; Bryant LK; Burgstad C; Nguyen NQ
    World J Gastroenterol; 2007 Aug; 13(29):3909-17. PubMed ID: 17663503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enteral administration of naloxone for treatment of opioid-associated intragastric feeding intolerance.
    Mixides G; Liebl MG; Bloom K
    Pharmacotherapy; 2004 Feb; 24(2):291-4. PubMed ID: 14998227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enteral nutrition delivery and energy expenditure in medical intensive care patients.
    Petros S; Engelmann L
    Clin Nutr; 2006 Feb; 25(1):51-9. PubMed ID: 16216393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of risk factors for enteral feeding intolerance screening in critically ill patients.
    Xu L; Wang T; Chen T; Yang WQ; Liang ZP; Zhu JC
    Saudi Med J; 2017 Aug; 38(8):816-825. PubMed ID: 28762434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary evidence for a medical nutrition therapy protocol: enteral feedings for critically ill patients.
    Kattelmann KK; Hise M; Russell M; Charney P; Stokes M; Compher C
    J Am Diet Assoc; 2006 Aug; 106(8):1226-41. PubMed ID: 16863719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Point-of-Care Gastric Ultrasound Confirms the Inaccuracy of Gastric Residual Volume Measurement by Aspiration in Critically Ill Children: GastriPed Study.
    Valla FV; Cercueil E; Morice C; Tume LN; Bouvet L
    Front Pediatr; 2022; 10():903944. PubMed ID: 35783320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nasogastric omeprazole: effects on gastric pH in critically Ill patients.
    Balaban DH; Duckworth CW; Peura DA
    Am J Gastroenterol; 1997 Jan; 92(1):79-83. PubMed ID: 8995942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastroparesis in the intensive care unit.
    Stojek M; Jasiński T
    Anaesthesiol Intensive Ther; 2021; 53(5):450-455. PubMed ID: 34816707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. To return or to discard? Randomised trial on gastric residual volume management.
    Juvé-Udina ME; Valls-Miró C; Carreño-Granero A; Martinez-Estalella G; Monterde-Prat D; Domingo-Felici CM; Llusa-Finestres J; Asensio-Malo G
    Intensive Crit Care Nurs; 2009 Oct; 25(5):258-67. PubMed ID: 19615907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.